SPROUTY-2 represses the epithelial phenotype of colon carcinoma cells via upregulation of ZEB1 mediated by ETS1 and miR-200/miR-150
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SPROUTY-2 represses the epithelial phenotype of colon carcinoma cells via upregulation of ZEB1 mediated by ETS1 and miR-200/miR-150
Authors
Keywords
-
Journal
ONCOGENE
Volume 35, Issue 23, Pages 2991-3003
Publisher
Springer Nature
Online
2015-10-12
DOI
10.1038/onc.2015.366
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The developing story of Sprouty and cancer
- (2014) Samar Masoumi-Moghaddam et al. CANCER AND METASTASIS REVIEWS
- Bidirectional modulation of endogenous EpCAM expression to unravel its function in ovarian cancer
- (2013) B T F van der Gun et al. BRITISH JOURNAL OF CANCER
- Epithelial Cell Adhesion Molecule (EpCAM) Regulates Claudin Dynamics and Tight Junctions
- (2013) Chuan-Jin Wu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- SPROUTY2 is a β-catenin and FOXO3a target gene indicative of poor prognosis in colon cancer
- (2013) P Ordóñez-Morán et al. ONCOGENE
- EpCAM contributes to formation of functional tight junction in the intestinal epithelium by recruiting claudin proteins
- (2012) Zili Lei et al. DEVELOPMENTAL BIOLOGY
- β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer
- (2012) Stephan P Tenbaum et al. NATURE MEDICINE
- A new model and modulator of pulmonary oedema
- (2012) Charlotte Harrison NATURE REVIEWS DRUG DISCOVERY
- SIX1 promotes epithelial–mesenchymal transition in colorectal cancer through ZEB1 activation
- (2012) H Ono et al. ONCOGENE
- Complex changes in alternative pre-mRNA splicing play a central role in the epithelial-to-mesenchymal transition (EMT)
- (2012) Claude C. Warzecha et al. SEMINARS IN CANCER BIOLOGY
- The level of claudin-7 is reduced as an early event in colorectal carcinogenesis
- (2011) Jette Bornholdt et al. BMC CANCER
- Deregulated expression of sprouty2 and microRNA-21 in human colon cancer: Correlation with the clinical stage of the disease
- (2011) Yin-Hsun Feng et al. CANCER BIOLOGY & THERAPY
- Differential gene expression signatures between colorectal cancers with and without KRAS mutations: Crosstalk between the KRAS pathway and other signalling pathways
- (2011) Toshiaki Watanabe et al. EUROPEAN JOURNAL OF CANCER
- Functional Cooperation between Snail1 and Twist in the Regulation ofZEB1Expression during Epithelial to Mesenchymal Transition
- (2011) Natàlia Dave et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression
- (2011) Rhonda L. Brown et al. JOURNAL OF CLINICAL INVESTIGATION
- TGF-β drives epithelial-mesenchymal transition through δEF1-mediated downregulation of ESRP
- (2011) K Horiguchi et al. ONCOGENE
- Sprouty 2 Is an Independent Prognostic Factor in Breast Cancer and May Be Useful in Stratifying Patients for Trastuzumab Therapy
- (2011) Dana Faratian et al. PLoS One
- GATExplorer: Genomic and Transcriptomic Explorer; mapping expression probes to gene loci, transcripts, exons and ncRNAs
- (2010) Alberto Risueño et al. BMC BIOINFORMATICS
- ZEB1-responsive genes in non-small cell lung cancer
- (2010) Robert M. Gemmill et al. CANCER LETTERS
- Zeb1 and twist are more commonly expressed in metastatic than primary lung tumours and show inverse associations with claudins
- (2010) H. Merikallio et al. JOURNAL OF CLINICAL PATHOLOGY
- Sprouty-2 controls c-Met expression and metastatic potential of colon cancer cells: sprouty/c-Met upregulation in human colonic adenocarcinomas
- (2010) C Holgren et al. ONCOGENE
- SPROUTY-2 and E-cadherin regulate reciprocally and dictate colon cancer cell tumourigenicity
- (2010) A Barbáchano et al. ONCOGENE
- Membrane-anchored serine protease matriptase regulates epithelial barrier formation and permeability in the intestine
- (2010) M. S. Buzza et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epithelial Integrity Is Maintained by a Matriptase-Dependent Proteolytic Pathway
- (2009) Karin List et al. AMERICAN JOURNAL OF PATHOLOGY
- Expression of sprouty2 inhibits B-cell proliferation and is epigenetically silenced in mouse and human B-cell lymphomas
- (2009) M. J. Frank et al. BLOOD
- HECT Domain-containing E3 Ubiquitin Ligase Nedd4 Interacts with and Ubiquitinates Sprouty2
- (2009) Francis Edwin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cell Density-Dependent Inhibition of Epidermal Growth Factor Receptor Signaling by p38 Mitogen-Activated Protein Kinase via Sprouty2 Downregulation
- (2009) A. Swat et al. MOLECULAR AND CELLULAR BIOLOGY
- Sprouty proteins, masterminds of receptor tyrosine kinase signaling
- (2008) Miguel A. Cabrita et al. ANGIOGENESIS
- Defective Claudin-7 Regulation by Tcf-4 and Sox-9 Disrupts the Polarity and Increases the Tumorigenicity of Colorectal Cancer Cells
- (2008) C. Darido et al. CANCER RESEARCH
- The Transcriptional Repressor ZEB1 Promotes Metastasis and Loss of Cell Polarity in Cancer
- (2008) S. Spaderna et al. CANCER RESEARCH
- A Double-Negative Feedback Loop between ZEB1-SIP1 and the microRNA-200 Family Regulates Epithelial-Mesenchymal Transition
- (2008) C. P. Bracken et al. CANCER RESEARCH
- A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells
- (2008) Ulrike Burk et al. EMBO REPORTS
- The miR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-cadherin Transcriptional RepressorsZEB1andZEB2
- (2008) Manav Korpal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cell polarity and cancer - cell and tissue polarity as a non-canonical tumor suppressor
- (2008) M. Lee et al. JOURNAL OF CELL SCIENCE
- The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
- (2008) Philip A. Gregory et al. NATURE CELL BIOLOGY
- Epigenetic inactivation of the ERK inhibitor Spry2 in B-cell diffuse lymphomas
- (2008) A Sánchez et al. ONCOGENE
- Hypermethylation-Modulated Downregulation of Claudin-7 Expression Promotes the Progression of Colorectal Carcinoma
- (2008) Fumihito Nakayama et al. PATHOBIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation